2017 Annual Meeting | C102 - Business Strategies for Payer Negotiations and/or How to Go off the Grid

Date Monday 04/24/17

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brad C. Klein, MD, MBA, FAAN

Topic(s)

Learning Objectives Participants should be able to develop an advanced understanding of their practice's clinical revenues; develop a comprehensive and critical assessment of the value of each payer; build a sensitivity analysis to project potential financial implications of leaving a payer if needed; understand potential steps in negotiations; and recognize and manage unfavorable payer contract clauses in participation agreements. Participants should also be able to understand specific challenges related to leaving government payers such as Medicare. Lastly, participants should be able to learn additional skillsets to help transition to a cash practice as well as strategies and techniques to grow, maintain, and succeed in caring for patients unencumbered by insurance contracts.

CME Available 2.00 CME credits

Core Competencies Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Interactive

Event Timeline
03:30 PM - 03:35 PM	Luncheon	Introduction Brad C. Klein, MD, MBA, FAAN
03:35 PM - 04:10 PM	Speaker	Negotiating with Payers Brad C. Klein, MD, MBA, FAAN
04:10 PM - 04:40 PM	Speaker	Transitioning Without Payers—Where to Begin Daryl Story, MD
04:40 PM - 05:10 PM	Speaker	Growing a Successful Practice without Payers Peter J. McAllister, MD, FAAN
05:10 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Brad C. Klein, MD, MBA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Daryl Story, MD	No disclosure on file
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.

��ɫ��

��ɫ��